Blackwell, J; Saxena, S; Pollok, RC (2018) Role of thiopurines as disease-modifying agents in Crohn's disease. Gut, 67 (12). pp. 2229-2230. ISSN 1468-3288 https://doi.org/10.1136/gutjnl-2017-315840
SGUL Authors: Pollok, Richard Charles G

Microsoft Word (.docx) Accepted Version Available under License ["licenses_description_publisher" not defined]. Download (16kB)

Item Type:	Article
Additional Information:	This article has been accepted for publication in Gut following peer review. The definitive copyedited, typeset version Blackwell J, Saxena S, Pollok RC Role of thiopurines as disease-modifying agents in Crohn’s disease Gut 2018;67:2229-2230 is available online at: http://dx.doi.org/10.1136/gutjnl-2017-315840
Keywords:	6-mercaptopurine, antibody targeted therapy, azathioprine, crohn’s disease, ibd surgery, 6-mercaptopurine, antibody targeted therapy, azathioprine, crohn’s disease, ibd surgery, Gastroenterology & Hepatology, 1103 Clinical Sciences, 1114 Paediatrics And Reproductive Medicine
SGUL Research Institute / Research Centre:	Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title:	Gut
ISSN:	1468-3288
Language:	eng
Dates:	Date Event December 2018 Published 3 January 2018 Published Online 15 December 2017 Accepted
Publisher License:	Publisher's own licence
PubMed ID:	29298871
	Go to PubMed abstract
URI:	http://sgultest.da.ulcc.ac.uk/id/eprint/110007
Publisher's version:	https://doi.org/10.1136/gutjnl-2017-315840

Actions (login required)

Edit Item